[{"address1": "2-5-1, Nihonbashi-Honcho", "address2": "Chuo-Ku", "city": "Tokyo", "zip": "103-8411", "country": "Japan", "phone": "81 3 3244 3000", "website": "https://www.astellas.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 14754, "companyOfficers": [{"maxAge": 1, "name": "Mr. Naoki  Okamura BSc", "age": 61, "title": "President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1958208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Atsushi  Kitamura", "title": "Senior Executive Officer & CFO", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nobue  Yasuda", "title": "General Manager of Finance & Accounting Department", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshitsugu  Shitaka Ph.D.", "title": "Chief Scientific Officer & Senior Managing Executive Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine B. Levitt", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Katsuyoshi  Sugita", "age": 56, "title": "Chief People Officer, Chief Ethics & Compliance Officer, EVP of HR and Representative Director", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stig  Ogata", "title": "Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tatjana  Dragovic", "title": "Senior VP and Head of Ethics & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nobuaki  Tanaka", "title": "President of Japan Commercial & Senior Corporate Executive", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jun  Kono", "title": "Senior Executive Officer & Head of Japan Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 2, "compensationRisk": 1, "shareHolderRightsRisk": 6, "overallRisk": 2, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.astellas.com/en/ir/", "maxAge": 86400, "priceHint": 2, "previousClose": 12.42, "open": 12.46, "dayLow": 12.44, "dayHigh": 12.48, "regularMarketPreviousClose": 12.42, "regularMarketOpen": 12.46, "regularMarketDayLow": 12.44, "regularMarketDayHigh": 12.48, "dividendRate": 0.46, "dividendYield": 0.037100002, "exDividendDate": 1711497600, "payoutRatio": 5.7759004, "fiveYearAvgDividendYield": 2.86, "beta": 0.294, "trailingPE": 155.875, "forwardPE": 29.0, "volume": 11884, "regularMarketVolume": 11884, "averageVolume": 208779, "averageVolume10days": 71110, "averageDailyVolume10Day": 71110, "bid": 12.46, "ask": 12.5, "bidSize": 40000, "askSize": 40000, "marketCap": 22319554560, "fiftyTwoWeekLow": 9.15, "fiftyTwoWeekHigh": 15.44, "priceToSalesTrailing12Months": 0.013115217, "fiftyDayAverage": 11.0844, "twoHundredDayAverage": 10.889, "trailingAnnualDividendRate": 70.0, "trailingAnnualDividendYield": 5.6360707, "currency": "USD", "enterpriseValue": 711932706816, "profitMargins": 0.01264, "floatShares": 1728681534, "sharesOutstanding": 1789859968, "heldPercentInstitutions": 0.00016000001, "impliedSharesOutstanding": 1801779968, "bookValue": 936.236, "priceToBook": 0.013319291, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.135, "netIncomeToCommon": 21518999552, "trailingEps": 0.08, "forwardEps": 0.43, "pegRatio": 6.38, "lastSplitFactor": "125:100", "lastSplitDate": 1396396800, "enterpriseToRevenue": 0.418, "enterpriseToEbitda": 2.543, "52WeekChange": -0.17222965, "SandP52WeekChange": 0.24014747, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ALPMY", "underlyingSymbol": "ALPMY", "shortName": "Astellas Pharma, Inc.", "longName": "Astellas Pharma Inc.", "firstTradeDateEpochUtc": 1262097000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4e39c582-516b-3483-995e-4cc15f900e7b", "messageBoardId": "finmb_874641", "gmtOffSetMilliseconds": -14400000, "currentPrice": 12.47, "targetHighPrice": 12.4, "targetLowPrice": 12.4, "targetMeanPrice": 12.4, "targetMedianPrice": 12.4, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 302928003072, "totalCashPerShare": 169.175, "ebitda": 279988994048, "totalDebt": 992657014784, "quickRatio": 0.657, "currentRatio": 0.903, "totalRevenue": 1701805948928, "debtToEquity": 59.212, "revenuePerShare": 949.525, "returnOnAssets": 0.0182, "returnOnEquity": 0.01322, "freeCashflow": 115574628352, "operatingCashflow": 172877004800, "earningsGrowth": 0.137, "revenueGrowth": 0.262, "grossMargins": 0.81509, "ebitdaMargins": 0.16452, "operatingMargins": 0.11270001, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]